Official Title
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs
Brief Summary

The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK of understudied drugs currently being administered to children per SOC as prescribed by their treating provider.

Recruiting
Coronavirus Infection (COVID-19)
Pulmonary Arterial Hypertension
Urinary Tract Infections in Children
Hypertension
Pain
Hyperphosphatemia
Primary Hyperaldosteronism
Edema
Hypokalemia
Heart Failure
Hemophilia
Menorrhagia
Insomnia
Pneumonia
Skin Infection
Arrythmia
Asthma in Children
Bronchopulmonary Dysplasia
Adrenal Insufficiency
Fibrinolysis; Hemorrhage
Attention Deficit Hyperactivity Disorder
Multisystem Inflammatory Syndrome in Children (MIS-C)
Kawasaki Disease
Coagulation Disorder
Down Syndrome

Drug: The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:

The prescribing of drugs to children is not part of this protocol. Participants will receive DOIs as prescribed by their treating provider.
Other Name: Array

Eligibility Criteria

Inclusion Criteria:

1. Participant is < 21 years of age

2. Parent/ Legal Guardian/ Adult Participant can understand the consent process and is
willing to provide informed consent/HIPAA:

3. (a) Participant is receiving one or more of the study drugs of interest at the time of
enrollment or (b) Participant is NOT receiving one or more of the study drugs of
interest but is SARS-COV-2 positive within 60 days prior to enrollment

Exclusion Criteria:

1. Participant has a known pregnancy Below exclusion criteria apply only to participants
receiving one or more of the study drugs of interest at the time of enrollment,

2. Has had intermittent dialysis within previous 24 hours

3. Has had a kidney transplant within previous 30 days

4. Has had a liver transplant within previous 1 year

5. Has had a stem cell transplant within previous 1 year

6. Has had therapeutic hypothermia within previous 24 hours

7. Has had plasmapheresis within the previous 24 hours

8. Has a Ventricular Assist Device

9. Has any condition which would make the participant, in the opinion of the
investigator, unsuitable for the study

Eligibility Gender
All
Eligibility Age
Minimum: 0 Years ~ Maximum: 20 Years
Countries
Canada
United States
Locations

Phoenix Children's Hospital
Phoenix, Arizona, United States

Arkansas Children's Hospital Research Institute
Little Rock, Arkansas, United States

University of California
Los Angeles, California, United States

Lucile Packard Children's Hospital
Palo Alto, California, United States

Colorado University Denver
Aurora, Colorado, United States

Alfred I. DuPont Hospital for Children
Wilmington, Delaware, United States

University of Florida Jacksonville Shands Medical Center
Jacksonville, Florida, United States

Kapiolani Womens and Childrens Medical Center
Honolulu, Hawaii, United States

Ann and Robert H. Lurie Childrens Hospital of Chicago
Chicago, Illinois, United States

Riley Hospital for Children at Indiana University
Indianapolis, Indiana, United States

University of Iowa Stead Family Children's Hospital
Iowa City, Iowa, United States

University of Kansas Medical Center
Kansas City, Kansas, United States

Wesley Medical Center
Wichita, Kansas, United States

University of Louisville Norton Childrens Hospital
Louisville, Kentucky, United States

Tulane Pediatrics
New Orleans, Louisiana, United States

Ochsner Baptist Clinical Trials Unit
New Orleans, Louisiana, United States

University of Maryland Medical Center
Baltimore, Maryland, United States

Boston Children's Hospital
Boston, Massachusetts, United States

Massachusetts General Hospital
Lexington, Massachusetts, United States

University of Minnesota
Minneapolis, Minnesota, United States

University of Mississippi Medical Center
Jackson, Mississippi, United States

Mississippi Center for Advanced Medicine
Madison, Mississippi, United States

Children's Mercy Hospital
Kansas City, Missouri, United States

Childrens Mercy Hospital
Kansas City, Missouri, United States

University of Nebraska Medical Center
Omaha, Nebraska, United States

Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States

University of New Mexico Health Science Center
Albuquerque, New Mexico, United States

Kravis Children's Hospital at Mt. Sinai
New York, New York, United States

University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States

Duke University Health System
Durham, North Carolina, United States

East Carolina University
Greenville, North Carolina, United States

New Hanover Regional Medical Center
Wilmington, North Carolina, United States

Cincinnati Childrens Hospital Medical Center
Cincinnati, Ohio, United States

Board of Regents of the University of Oklahoma
Oklahoma City, Oklahoma, United States

Oregon Health and Science University
Portland, Oregon, United States

Pennsylvania State University--Hershey Children's Hospital
Hershey, Pennsylvania, United States

Rhode Island Hospital
Providence, Rhode Island, United States

Medical University of South Carolina Children's Hospital
Charleston, South Carolina, United States

University of South Carolina
Columbia, South Carolina, United States

Avera McKennan Hospital & University Medical Center
Sioux Falls, South Dakota, United States

Monroe Carell Jr. Children's Hospital at Vanderbilt
Nashville, Tennessee, United States

Dell Children's Medical Center of Central Texas
Austin, Texas, United States

University of Texas-Southwestern Medical Center
Dallas, Texas, United States

University of Texas--Memorial Hermann Texas Medical Center
Houston, Texas, United States

Seattle Children's Hospital
Seattle, Washington, United States

West Virginia University Hospital
Morgantown, West Virginia, United States

University of Wisconsin
Madison, Wisconsin, United States

University Wisconsin
Madison, Wisconsin, United States

Medical College of Wisconsin
Milwaukee, Wisconsin, United States

Children's Hospital of Eastern Ontario
Ottawa, Ontario, Canada

The Hospital for Sick Children
Toronto, Ontario, Canada

CHU Sainte-Justine
Montréal, Quebec, Canada

Contacts

Chi Hornik
(919) 260-7626
chi.hornik@duke.edu

Jerry Kirchner
(919) 812-1798
jerry.kirchner@duke.edu

Chi Hornik, Principal Investigator
Duke Clinical Research Institute

Duke University
NCT Number
MeSH Terms
Infections
Communicable Diseases
Coronavirus Infections
Urinary Tract Infections
Pulmonary Arterial Hypertension
Bronchopulmonary Dysplasia
Down Syndrome
Menorrhagia
Hypertension
Hemostatic Disorders
Mucocutaneous Lymph Node Syndrome
Blood Coagulation Disorders
Hyperphosphatemia
Hypokalemia
Adrenal Insufficiency
Hyperaldosteronism
Syndrome
Hemorrhage
Attention Deficit Disorder with Hyperactivity
Metformin
Interferons
Ritonavir
Ribavirin
Lopinavir
Oseltamivir
Remdesivir
Azithromycin
Clindamycin
Meropenem
Voriconazole
Ceftazidime
Cefepime
Fosfomycin
Cefdinir
Dexamethasone
Budesonide
Hydrocortisone
Colchicine
Amiodarone
Bosentan
Guanfacine
Labetalol
Nicardipine
Nifedipine
Milrinone
Furosemide
Spironolactone
Dexmedetomidine
Oxycodone
Gabapentin
Nalbuphine
Clobazam
Zolpidem
Risperidone
Amphetamine
Dextroamphetamine
Sertraline
Tranexamic Acid
Aminocaproic Acid
Terbutaline
Sevelamer